Clinical Trials on Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor in China
Total 2 results
-
Tianjin Chest HospitalRecruitingAcute Coronary Syndrome | Proprotein Convertase Subtilisin/Kexin Type 9 InhibitorChina
-
Shenzhen People's HospitalRecruitingEvaluate the Efficacy and Safety of IBI306 in Subjects With Homozygous Familial HypercholesterolemiaLipid Metabolism Disorders | Familial Hypercholesterolemia - Homozygous | Proprotein Convertase Subtilisin/Kexin 9China